Recently, intraventricular injection of AQP4-positive IgG together with human complement has been shown to induce NMO-like inflammatory brain lesions [20], and passive transfer of NMO-IgG to EAE-rats induced an exacerbation of the disease and NMO-like lesions [21,22]. The gene discussed is AQP4; the disease is neuromyelitis optica.